Manuela Matesan
University of Washington, USA
Title: PET imaging in lymphoma: An update on clinical trails guidelines and clinical practice indications
Biography
Biography: Manuela Matesan
Abstract
This presentation includes a case-based review illustrating the importance in clinical practice of 18F-FDG -PET images utilization for the initial staging and treatment response assessment in lymphoma patients. A discussion regarding 18F-FDG -avidity for different types of lymphomas and the side effects of the first and second line lymphoma treatments which every nuclear medicine radiologist needs to be familiar with in order to avoid pitfalls in image interpretation is provided. There is included also an overall review of changes presented in the new response evaluation criteria RECIL 2017 as compared to the standard previously published criteria. Learning Objectives include identify differences in Fluorodeoxyglucose (18F-FDG) -avidity based on the histopathologic subtype of lymphoma and becoming familiar with particularities of different types of lymphoma; Summarize the major indications to perform FDG-PET in patients with lymphoma and pearls and pitfalls in image interpretation. Discuss criteria for oncologic response assessmentfamiliar with the side effects from the first and second line medication used in lymphoma.